BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23749687)

  • 1. Risk of subsequent malignancies in survivors of childhood leukemia.
    Perkins SM; Dewees T; Shinohara ET; Reddy MM; Frangoul H
    J Cancer Surviv; 2013 Dec; 7(4):544-50. PubMed ID: 23749687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Risk of Subsequent Malignant Neoplasms Among Childhood and Adolescent Lymphoma Survivors (1975-2013): A Population-Based Predictive Nomogram.
    Liu J; Zheng Q; Beeraka NM; Zhang X; Li T; Song R; Zhao D; Fan R
    Oncologist; 2023 Sep; 28(9):e765-e773. PubMed ID: 37177980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.
    Friedman DL; Whitton J; Leisenring W; Mertens AC; Hammond S; Stovall M; Donaldson SS; Meadows AT; Robison LL; Neglia JP
    J Natl Cancer Inst; 2010 Jul; 102(14):1083-95. PubMed ID: 20634481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
    Rihani R; Bazzeh F; Faqih N; Sultan I
    Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of high mortality in long term survivors of childhood medulloblastoma.
    Ning MS; Perkins SM; Dewees T; Shinohara ET
    J Neurooncol; 2015 Apr; 122(2):321-7. PubMed ID: 25557108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.
    Essig S; Li Q; Chen Y; Hitzler J; Leisenring W; Greenberg M; Sklar C; Hudson MM; Armstrong GT; Krull KR; Neglia JP; Oeffinger KC; Robison LL; Kuehni CE; Yasui Y; Nathan PC
    Lancet Oncol; 2014 Jul; 15(8):841-51. PubMed ID: 24954778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of second malignancies among survivors of pediatric thyroid cancer.
    Adly MH; Sobhy M; Rezk MA; Ishak M; Afifi MA; Shafie AE; Ali MA; Zekri W; Alfaar AS; Rashed WM
    Int J Clin Oncol; 2018 Aug; 23(4):625-633. PubMed ID: 29492793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia.
    Hijiya N; Hudson MM; Lensing S; Zacher M; Onciu M; Behm FG; Razzouk BI; Ribeiro RC; Rubnitz JE; Sandlund JT; Rivera GK; Evans WE; Relling MV; Pui CH
    JAMA; 2007 Mar; 297(11):1207-15. PubMed ID: 17374815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup.
    Allodji RS; Hawkins MM; Bright CJ; Fidler-Benaoudia MM; Winter DL; Alessi D; Fresneau B; Journy N; Morsellino V; Bárdi E; Bautz A; Byrne J; Feijen ELA; Teepen JC; Vu-Bezin G; Rubino C; Garwicz S; Grabow D; Gudmundsdottir T; Guha J; Hau EM; Jankovic M; Kaatsch P; Kaiser M; Linge H; Muraca M; Llanas D; Veres C; Øfstaas H; Diallo I; Mansouri I; Ronckers CM; Skinner R; Terenziani M; Wesenberg F; Wiebe T; Sacerdote C; Jakab Z; Haupt R; Lähteenmäki P; Zaletel LZ; Kuehni CE; Winther JF; Michel G; Kremer LCM; Hjorth L; Haddy N; de Vathaire F; Reulen RC
    Eur J Cancer; 2019 Aug; 117():71-83. PubMed ID: 31260818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second malignancies after childhood noncentral nervous system solid cancer: Results from 13 cancer registries.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Olsen JH; Tracey E; Pukkala E; Weiderpass E; Brewster DH; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    Int J Cancer; 2011 Oct; 129(8):1940-52. PubMed ID: 21520035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015.
    Turcotte LM; Liu Q; Yasui Y; Arnold MA; Hammond S; Howell RM; Smith SA; Weathers RE; Henderson TO; Gibson TM; Leisenring W; Armstrong GT; Robison LL; Neglia JP
    JAMA; 2017 Feb; 317(8):814-824. PubMed ID: 28245323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study.
    Dixon SB; Chen Y; Yasui Y; Pui CH; Hunger SP; Silverman LB; Ness KK; Green DM; Howell RM; Leisenring WM; Kadan-Lottick NS; Krull KR; Oeffinger KC; Neglia JP; Mertens AC; Hudson MM; Robison LL; Armstrong GT; Nathan PC
    J Clin Oncol; 2020 Oct; 38(29):3418-3429. PubMed ID: 32706634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia.
    Pui CH; Cheng C; Leung W; Rai SN; Rivera GK; Sandlund JT; Ribeiro RC; Relling MV; Kun LE; Evans WE; Hudson MM
    N Engl J Med; 2003 Aug; 349(7):640-9. PubMed ID: 12917300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
    Chow EJ; Friedman DL; Stovall M; Yasui Y; Whitton JA; Robison LL; Sklar CA
    Pediatr Blood Cancer; 2009 Sep; 53(3):432-7. PubMed ID: 19459201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group.
    Bhatia S; Yasui Y; Robison LL; Birch JM; Bogue MK; Diller L; DeLaat C; Fossati-Bellani F; Morgan E; Oberlin O; Reaman G; Ruymann FB; Tersak J; Meadows AT;
    J Clin Oncol; 2003 Dec; 21(23):4386-94. PubMed ID: 14645429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
    Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
    J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: a report from the childhood cancer survivor study.
    Pappo AS; Armstrong GT; Liu W; Srivastava DK; McDonald A; Leisenring WM; Hammond S; Stovall M; Neglia JP; Robison LL
    Pediatr Blood Cancer; 2013 Mar; 60(3):461-6. PubMed ID: 22887858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone and Soft-Tissue Sarcoma Risk in Long-Term Survivors of Hereditary Retinoblastoma Treated With Radiation.
    Kleinerman RA; Schonfeld SJ; Sigel BS; Wong-Siegel JR; Gilbert ES; Abramson DH; Seddon JM; Tucker MA; Morton LM
    J Clin Oncol; 2019 Dec; 37(35):3436-3445. PubMed ID: 31622129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.